Patients with Multiple Sclerosis Who Develop Immunogenicity to Interferon-Beta Have Distinct Transcriptomic and Proteomic Signatures Prior to Treatment Which Are Associated with Disease Severity
Clinical Immunology(2024)
Key words
Multiple sclerosis,Progression,Biomarkers,Immunogenicity,Anti-drug antibodies
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined